ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Monthly News Review of PharmaSources (February) - Business
March 14, 2023On the business, Keymed Biosciences Inc. and Lepu Biopharma jointly announced an exclusive global licensing agreement with AstraZeneca for CMG901. In terms of the listing, Kelun Pharmaceutical's subsidiary Kelun Biotech intends to go public in Hong Kong. -
Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer
January 21, 2025Innovent and ASK Pharm jointly announce NMPA's approval of limertinib for treating lung cancer, with efficacy and safety proven and first - line treatment review ongoing. -
How Hot is the Third-generation EGFR-TKI?
April 03, 2019BPI-7711 is a third-generation EGFR-TKI, making Beta Pharma the fourth Chinese pharmaceutical enterprises that enter the Phase III clinical trial of the variety following ACEA, Hansoh, and Allist.
Pharma Sources Insight January 2025
